Key regions: China, South Korea, Japan, Canada, India
The Wound Care (Pharmacies) market in CIS is experiencing steady growth due to increasing customer preferences for advanced wound care products, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in the Wound Care (Pharmacies) market in CIS are shifting towards advanced wound care products that offer faster healing and better outcomes. Customers are increasingly seeking products that are easy to use, provide effective wound management, and promote faster healing. This preference is driven by the growing awareness of the importance of proper wound care and the availability of a wide range of wound care products in pharmacies. Trends in the market indicate a rising demand for specialized wound care products such as antimicrobial dressings, foam dressings, and hydrocolloid dressings. These products offer advanced wound healing properties and are highly effective in managing various types of wounds. Additionally, there is a growing trend towards the adoption of wound care products that are compatible with modern wound care techniques such as negative pressure wound therapy and bioactive wound dressings. Local special circumstances in the CIS region also contribute to the development of the Wound Care (Pharmacies) market. The region has a high prevalence of chronic wounds, including diabetic foot ulcers and pressure ulcers, which require specialized wound care products for effective management. The aging population in the region further drives the demand for wound care products as older individuals are more prone to chronic wounds and require specialized care. Underlying macroeconomic factors such as increasing healthcare expenditure and improving healthcare infrastructure also play a significant role in the development of the Wound Care (Pharmacies) market in CIS. The governments in the region are investing in the healthcare sector, leading to improved access to healthcare services and a greater availability of wound care products in pharmacies. Additionally, the growing middle-class population and rising disposable incomes contribute to increased healthcare spending, including the purchase of wound care products. In conclusion, the Wound Care (Pharmacies) market in CIS is developing due to customer preferences for advanced wound care products, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. The demand for specialized wound care products, driven by a growing awareness of proper wound care and the availability of a wide range of products, is fueling market growth. Additionally, the high prevalence of chronic wounds, improving healthcare infrastructure, and increasing healthcare expenditure in the region contribute to the development of the market.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
